-
AboutShanxi Nuocheng Pharmaceutical Co., Ltd. was established in August 2008. It is located in Huairen High-tech Industrial Park, Shuozhou City, Shanxi Province. It is a national "high-tech enterprise" and the company covers an area of 330 acres.
-
ProductsOur company can produce anti-tumor, anti-fungal, antibiotics, nutrition, anesthesia, cardiovascular and cerebrovascular products such as 6 categories of series of products, the company's existing domestic products 73 product specifications and foreign products 22 product specifications.
-
NewsFrom 2019 to now, the company has attracted 38 kinds of generic drugs developed by 12 scientific research institutes such as Beijing Tongrentang Pharmaceutical Technology Development Co., Ltd. and Shanghai Rongdi Biotechnology Co., Ltd. to land in our company. After all of them are put into production, the annual output value can be increased by 1 billion and the profit can be about 0.2 billion.
-
ProductionThe API synthesis workshop includes 2 API production lines, 4 supporting warehouses and a 800 ㎡ sewage treatment station. The workshop has complete functions and can realize multi-product sharing. The existing API varieties are fluorenylmethoxycarbonyl-N-hydroxysuccinic acid imide ester (Fmoc-OSu), cinepazide maleate, fasudil, cimetidine, dimidamol, glycyrrhizic acid monopotassium salt and other 8 API varieties.
-
QualityAs a key construction project in Shanxi Province, we have been affirmed, cared and cared for by leaders at all levels. Leaders at all levels of the province, city and county have visited our company many times to guide the research work.
In order to meet the new version of GMP certification inspection pledging conference
Date:
2011-10-23
In order to meet the new version of GMP certification inspection pledging conference 2011-10-23 October 2011, the new revised version of GMP was promulgated and implemented. The pharmaceutical industry is facing a severe test. For our company, it is even more difficult to prepare for the war. In order to meet the new version of GMP inspection, our company held a pledging conference on October 23, 2011 to implement the "Good Manufacturing Practice (Revised in 2010)" to raise a new level in ideology and consciousness and lay the foundation for successfully passing the new version of GMP certification inspection. Deputy Chief Qian Shengli of the swearing meeting company is determined to represent all the swearing meeting Liu Jia
2011-10-23
In October 2011,New RevisionGMPPromulgation and implementation, the pharmaceutical industry is facing a severe test, for our company is even more last stand, preparing for war without delay.
To welcome the new versionGMPCheck, my company inHeld on October 23, 2011 to implement the "medicineProduct production management specifications (Revised in 2010)The pledging conference will raise a new height ideologically and consciously in order to successfully pass the new edition.GMPCertification inspection lays the foundation.
Pledge General Assembly Company Vice President Qian Shengli Table Determination
Liu Jia spoke on behalf of all middle-level cadres at the oath meeting.
Key words:
Biopharmaceuticals
2023-07-02
Fuze the world, a promise will be made!
Norcheng Pharmaceuticals
Copyright©2023 Shanxi Nuocheng Pharmaceutical Co., Ltd.